Bimagrumab, CAS 1356922-05-8

Product Description: Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness[1][2].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Heymsfield SB, et, al. Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial. JAMA Netw Open. 2021 Jan 4;4(1):e2033457. /[2]Lach-Trifilieff E, et, al. An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol. 2014 Feb;34(4):606-18.

CAS Number: 1356922-05-8

Molecular Weight: N/A

Compound Purity: 99.30

Research Area: Metabolic Disease

Solubility: H2O

Target: TGF-β Receptor

• Artikelnummer: MEXHY-P99355-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99355-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK